arrow_back Back Filing freshness 10-Q Q1 FY2025 SEC EDGAR

P3 Health Partners Inc.

PIII
$11.57 ▲ +0.69 (+6.34%) at close
Healthcare ·Services-Health Services ·USServices-Health Services
24 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
56
Health
Fair
Moderately Bullish
auto_awesome

Analytical Summary

P3 Health Partners Inc. demonstrates solid fundamentals with strength in Return on Common Equity (%). Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $38.0M
Dividend Yield
Revenue Growth 3.5%
Op. Margin 2.1%
ROIC -1.0%
FCF / Share $-8.35
Trailing P/E 31.3x
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

24-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$386.39M
↑ +3.5%
Net Income Profit after all expenses
$1.22M
↑ +101.6%
Operating Margin Operating profit as % of sales
2.1%
↑ +105.3% 12th
FCF / Share Free cash flow per share
$-8.35
↑ +18.6%
Long-Term Debt Long-term obligations
$311.00M
↑ +36.2%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
15
Returns
99
Financial Health
62
Cash Quality
42

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 24 quarters